Helen Stone

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Thomas M Drake, Annemarie B Docherty, Ewen M. Harrison et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 239 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy

Irfan Ullah, Jérémie Prévost, Mark S. Ladinsky et al. · Immunity · 2021 · 237 citations · Full text

Pharmacy, Immunology, Infectious Diseases +13

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial

Surinder S. Birring, Marlies Wijsenbeek, Sanjay Agrawal et al. · The Lancet Respiratory Medicine · 2017 · 119 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Disease associations in alpha-1-antitrypsin deficiency

Helen Stone, Anita Pye, Robert A. Stockley · Respiratory Medicine · 2013 · 54 citations · Full text

Life Sciences, Pathology, Pathophysiology +4